Instant drug release is the most commonly used release profile for solid hard tablets. It releases the active ingredient immediately when it reaches the stomach, meaning the active drug ingredient gets to you quicker than if you were to take an extended release drug that becomes bioavailable later in the digestive system.
For those patients who require a modest amount of THC, Canntab’s 5:1 CBD and THC formulation will be available in IR tablets.
Canntab’s unique delivery method for medical cannabis sets a new standard of patient experience and convenience. Comparatively, other methods don’t offer the same therapeutic effect.
Smoking cannabis can result in a large initial dose of the drug, followed by an equally quick drop in the effect.
While Edibles offer a convenient delivery method, it’s one that is unpredictable, slow to take effect and eventually subside.
✓ Short duration for accurate control throughout the day
✓ Avoids unpleasant tastes and potential allergic reactions in the digestive tract
✓ Available in CBD, THC and CBD: THC
✓ Our proprietary processes allows us to create predictable and consistent hard pill formulations that Strats with cannabis oil in water emulsions, a unique process in the industry to date.
Instacann’s tablets have been manufactured using an innovative Self-Micro- Emulsifying Drug Delivery System (SMEDDS). SMEDDS increase the absorption of lipophilic drugs such as THC taken orally.
Canntab formulated an innovative solidification technique and developed a solid rapid eroding tablet dosage form. The tablet also contains a permeability enhancer which relaxes the tight junction of oral mucosa which in return increases drug absorption. SMEDDS offer a number of advantages in the absorption of the drug via intestinal lymphatic transport. Drugs that are highly lipophilic and lipid may induce the extent of lymphatic transport and will increase bioavailability in a direct way or indirectly via a reduction in first-pass metabolism. Lipids in the GI tract stimulate bile salts (BS) and endogenous biliary lipids including phospholipids (PL) and cholesterol (CH) with many enzymes, leading to the formation of mixed micelles, which increase in the solubilization capacity of the GI tract.
This patented innovative solid SMEDDS promotes the intestinal lymphatic uptake of Cannabinoids in lipid-based pharmaceutical formulations.
This delivery system enables micro-dosing of Cannabinoids for medicinal application.
Related Products
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
choosing a selection results in a full page refresh
Item added to your cartItem added to your cartItems added to your cart
